Molecule Details
| InChIKey | OTMLAWRVLMYMDF-UHFFFAOYSA-N |
|---|---|
| Compound Name | 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol |
| Canonical SMILES | CNc1nc(C)c(-c2ccnc(Nc3ccc(O)cc3)n2)s1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.16 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB04407 |
|---|---|
| Drug Name | 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol |
| CAS Number | nan |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Cross-references: BindingDB: 8054 CHEMBL47590 ChemSpider: 394905 PDB: CK6 PubChem:447960 PubChem:46505843 ZINC: ZINC000002047390
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P24941 | CDK2 | Cyclin-dependent kinase 2 | binder | targets |